Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Journal of Neurosurgical Sciences 2019 December;63(6) > Journal of Neurosurgical Sciences 2019 December;63(6):737-42

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

THERAPEUTICAL NOTE   

Journal of Neurosurgical Sciences 2019 December;63(6):737-42

DOI: 10.23736/S0390-5616.16.03362-2

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Use of gelatin hemostatic matrices in patients with intraparenchymal hemorrhage and drug-induced coagulopathy

Jacopo DEL VERME , Carlo CONTI, Franco GUIDA

Department of Neurosurgery, Ospedale dell’Angelo, Mestre, Venice, Italy



In the routine practice of neurosurgery, the attainment of appropriate hemostasis during and after surgery is of the utmost importance. In the last few years, we have noticed that in several cases the standard coagulation methods (bipolar, Tabotamp, Spongostan) were not sufficient; in particular, patients with intraparenchymal hemorrhage under anticoagulant or antiplatelet therapy were observed to be the most difficult hemostasis cases, and thus those most frequently subjected to gelatin hemostatic matrices. We report our trial on 57 patients under anticoagulant or antiplatelet therapy and with intraparenchymal hemorrhage in which gelatin hemostatic matrices were used. The excellent results both in terms of outcome and decreased bleeding allow for regarding such a practice as safe and reproducible in these cases.


KEY WORDS: Cerebral hemorrhage; Anticoagulants; Platelet aggregation inhibitors

top of page